Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7957
Reference
Drug alert 34/2023
Name
Drug alert class 3 – 34 2023 – Class 3 medicines recall - action within 5 days - Theramex HQ UK Ltd – Evorel Sequi
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
MEDICINES RECALL
Description
Theramex has informed the MHRA that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti patches. Only the batch listed in this notification is affected. The remainder of the batch is being recalled as a precautionary measure. The batch is comprised of 150,132 packs. So far 24 packs have been confirmed to contain the incorrect combination and the investigation has concluded that the issue is limited to a small number of packs only.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2023-09-05 00:00:00
Click to go back to homepage